Bio-Techne Corporation TECH
Regular-session close
After hours · Nov 20, 5:25 PM ET
- YTD
- +23.57%
- 1 year
- +23.74%
Held by funds
248 US ETFs and mutual funds hold TECH · largest positions
- VOO 0.02% of fund $302.46M
- VTI 0.02% of fund $285.65M
- VB 0.14% of fund $255.45M
- RSP 0.20% of fund $205.78M
- SEQ 2.57% of fund $164.32M
- IVV 0.02% of fund $153.35M
- FXAIX 0.02% of fund $147.46M
- VBK 0.33% of fund $142.87M
- SPY 0.02% of fund $139.32M
- FBT 3.45% of fund $99.09M
- IBB 0.82% of fund $88.19M
- XLV 0.18% of fund $83.02M
- FLCNX 0.20% of fund $74.37M
- VINIX 0.02% of fund $59.79M
- IWR 0.09% of fund $48.66M
- FSMDX 0.09% of fund $43.79M
- VHT 0.15% of fund $34.91M
- SCHM 0.24% of fund $33.90M
- SPYM 0.02% of fund $32.89M
- NIZ 0.06% of fund $31.12M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.07% | 14,250,400 | 1.04B | Sep 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 10,250,628 | 744.91M | Sep 29, 2026 |
| HBK Investments L P | 4.92% | 7,732,128 | 561.89M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.04% | 6,348,862 | 461.37M | Sep 29, 2026 |
| FIL LTD | 3.99% | 6,272,729 | 455.84M | Sep 29, 2026 |
| State Street Corporation | 3.85% | 6,045,884 | 439.35M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 4,968,867 | 361.09M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.58% | 4,056,808 | 294.81M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.28% | 3,586,562 | 260.64M | Jun 29, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1.72% | 2,707,457 | 196.75M | Sep 29, 2026 |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 1.66% | 2,604,519 | 189.27M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 2,089,474 | 151.84M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs TECH, and what each was last paid
Kim Kelderman, Chief Executive Officer, President & DirectorAverage age 55
| Name | Title | Pay | Age |
|---|---|---|---|
| Kim Kelderman | Chief Executive Officer, President & Director | $1.89M | 59 |
| James T. Hippel | Executive Vice President of Finance & Chief Financial Officer | $1.38M | 55 |
| William A. Geist | President of Protein Sciences Segment | $1.06M | 57 |
| Shane Bohnen | Senior Vice President, General Counsel, Corporate Secretary & Chief Sustainability Officer | $884K | 51 |
| Steve Crouse | President of Diagnostics & Spatial Biology Segment | $668K | 53 |
| Bernie Andruss | Senior Vice President of Bio-Techne Diagnostics Division | — | — |
| Gary J. Latham | Vice President & Chief Technology Officer | — | — |
| Peter Schuessler | Senior Vice President of EMEA & Commercial Effectiveness | — | — |
| David Clair | Vice President of Investor Relations | — | — |
| Dylan Malayter | Senior Vice President of Reagent Solutions Division | — | — |
| Luca Cicchetti | Managing Director | — | — |
| Martin Wirtz | Senior Vice President of Strategy & Corporate Development | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAUMGARTNER ROBERT V | Director | Stock Award(Grant) | Oct 28, 2026 | 59,634 |
| BUSHMAN JULIE L. | Director | Stock Award(Grant) | Oct 28, 2026 | 11,525 |
| GEIST WILLIAM | Officer | Conversion of Exercise of derivative security | Aug 13, 2026 | 24,943 |
| HIGGINS JOHN L | Director | Stock Award(Grant) | Oct 28, 2026 | 80,004 |
| HIPPEL JAMES | Chief Financial Officer | Conversion of Exercise of derivative security | Oct 29, 2026 | 176,720 |
| KEEGAN JOSEPH D | Director | Stock Award(Grant) | Oct 28, 2026 | 18,161 |
